Je was op zoek naar: overactive (Engels - Maltees)

overactive thyroid.
tirojde attiva żżejjed.

overactive thyroid gland
glandola tat-tirojde attiva ħafna

an underactive or overactive thyroid
tirojde taħdem bil-mod jew tgħaġġel iżżejjed

hyperthyroidism (overactive thyroid gland)
ipertirojdiżmu (glandola tat-tirojde attiva żżejjed)

mirabegron – used to treat overactive bladders
mirabegron – użati biex jikkuraw bżieżaq tal-awrina attivi żżejjed

- overactive thyroid gland has been reported commonly
- glandola tat- tirojde aktar attiva ġiet rapportata b’ mod aktar ta ’ spiss

emselex reduces the activity of an overactive bladder.
emselex inaqqas l-attività ta’ bużżieqa tal-awrina attiva żżejjed.

betmiga is used in adults with overactive bladder syndrome.
betmiga jintuża f’persuni adulti li jkollhom is-sindrome ta’ bużżieqa tal-awrina attiva b’mod eċċessiv.

hormone system disorders: overactive and underactive thyroid gland
disturbi fis-sistema tal-ormoni: glandola tat-tirojde attiva ż-żejjed jew mhux attiva biżżejjed

an overactive immune system has been linked to inflammatory diseases.
sistema immuni attiva żżejjed ġiet marbuta ma’ mard infjammatorju.

stopping treatment may result in recurrence of symptoms of overactive bladder.
it-twaqqif tal-kura jista‟ jwassal biex is-sintomi tal-bużżieqa tal-awrina iperattiva jerġgħu jokkorru.

blood vessel disease, a history of stroke, or an overactive thyroid.
pressjoni għolja tad- demm, mard tal- qalb jew tal- vini tad- demm, passat mediku ta ’ puplesija, jew għandek tirojde attiva żżejjed.

darifenacin hydrobromide is a substance which reduces the activity of an overactive bladder.
darifenacin hydrobromide huwa sustanza li tnaqqas l- attività ta ’ bużżieqa ta ’ l- awrina attiva żżejjed.

kentera gel was compared with placebo in one main study in 789 patients with overactive bladders.
fi studju prinċipali kentera tqabbel ma’ plaċebo fi 789 pazjent li kellhom il-bużżieqa tal-urina iperattiva.

oxybutynin has been available as a tablet for the treatment of overactive bladder since the 1970s.
l-ossibutinina ilha disponibbli f’pillola għat-trattament tal-bżieżaq tal-urina iperattivi mis-snin sebgħin.

betmiga has been studied in three main studies involving 4,611 patients with overactive bladder syndrome.
betmiga ġie studjat fi tliet studji ewlenin li kienu jinvolvu 4,611-il pazjent li għandhom is-sindrome ta’ bużżieqa tal-awrina attiva b’mod eċċessiv.

do not stop taking betmiga without talking to your doctor first, as your overactive bladder symptoms may come back.
tiqafx tieħu betmiga mingħajr ma l-ewwel tkellem lit-tabib tiegħek, billi s-sintomi tal-bużżieqa tal- awrina iperattiva jistgħu jerġgħu jitfaċċaw.

emselex has been studied in four main studies in a total of 2,078 male and female patients with symptoms of overactive bladder.
emselex ġie eżaminat f' erba 'studji ewlenin fuq total ta' 2, 078 pazjent taż- żewġ sessi b' sintomi tal - bużżieqa iperattiva.

symptomatic treatment of urge incontinence and/ or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.
għall- kura tas- sintomi ta ’ impulsi qawwija ta ’ inkontinenza u/ jew f’ persuni li jkollhom bżonn jgħamlu l- awrina aktar ta ’ spiss u b’ urġenza akbar, bħal ma jista ’ jiġri f’ dawk il- pazjenti li jkollhom bużżieqa ta ’ l- awrina attiva żżejjed.

do not stop taking toviaz without talking to your doctor, as your symptoms of overactive bladder may come back again or become worse once you stop taking toviaz.
twaqqafx toviaz mingħajr ma tgħarraf it-tabib tiegħek għaliex is-sintomi tiegħek ta’ bużżieqa ta’ l- awrina attiva ħafna jistgħu jerġgħu jitfaċċaw, u jmorru għall-agħar ladarba tieqaf tieħu toviaz.